- Home
- GDTC vs SCNX Comparison
GDTC vs SCNX Comparison
Compare GDTC & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- SCNX
- Stock Information
- Founded
- GDTC 2018
- SCNX 2010
- Country
- GDTC Singapore
- SCNX United States
- Employees
- GDTC N/A
- SCNX N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- GDTC Health Care
- SCNX Health Care
- Exchange
- GDTC Nasdaq
- SCNX Nasdaq
- Market Cap
- GDTC 28.0M
- SCNX 33.6M
- IPO Year
- GDTC 2023
- SCNX 2020
- Fundamental
- Price
- GDTC $2.35
- SCNX $0.91
- Analyst Decision
- GDTC Buy
- SCNX
- Analyst Count
- GDTC 1
- SCNX 0
- Target Price
- GDTC $5.00
- SCNX N/A
- AVG Volume (30 Days)
- GDTC 9.6K
- SCNX 65.2K
- Earning Date
- GDTC 01-01-0001
- SCNX 05-12-2025
- Dividend Yield
- GDTC N/A
- SCNX N/A
- EPS Growth
- GDTC N/A
- SCNX N/A
- EPS
- GDTC N/A
- SCNX N/A
- Revenue
- GDTC $368,838.00
- SCNX $146,901.00
- Revenue This Year
- GDTC $5.37
- SCNX N/A
- Revenue Next Year
- GDTC N/A
- SCNX N/A
- P/E Ratio
- GDTC N/A
- SCNX N/A
- Revenue Growth
- GDTC N/A
- SCNX N/A
- 52 Week Low
- GDTC $1.20
- SCNX $0.69
- 52 Week High
- GDTC $4.05
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- GDTC 49.94
- SCNX N/A
- Support Level
- GDTC $2.26
- SCNX N/A
- Resistance Level
- GDTC $2.60
- SCNX N/A
- Average True Range (ATR)
- GDTC 0.13
- SCNX 0.00
- MACD
- GDTC 0.00
- SCNX 0.00
- Stochastic Oscillator
- GDTC 40.38
- SCNX 0.00
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.